Norden Gregory

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
6 17% Buy
34 71% Buy
47 69% Buy
Norden Gregory's trades of Royalty Pharma PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-15 2026-05-14 PlS Planned sale
48,931 +36.6%
270.45
US$3,460,179
48,931 +36.6% 270.45 US$3,460,179
2026-05-14 2026-05-14 PrS Proposed sale
17,618
202.53
US$478,367
17,618 202.53 US$478,367
2025-08-11 2025-08-11 PrS Proposed sale
39,449
196.82
US$557,692
39,449 196.82 US$557,692
2025-08-11 2025-08-11 S Sale
33,500 -14.7%
36.23
US$1,213,749
33,500 -14.7% 36.23 US$1,213,749
2023-03-08 2023-03-07 B Purchase
12,500 +110.6%
9.84
US$123,000
12,500 +110.6% 9.84 US$123,000
2021-11-09 2021-11-05 S Sale
4,500 -53.6%
216.07
US$972,315
4,500 -53.6% 216.07 US$972,315
2020-12-09 2020-12-07 S Sale
24 -1.3%
58.90
US$1,414
24 -1.3% 58.90 US$1,414
2020-12-09 2020-12-07 S Sale
10,382 -84.4%
58.32
US$605,478
10,382 -84.4% 58.32 US$605,478
2020-08-13 2020-08-13 S Sale
10,000 -84.1%
38.83
US$388,250
10,000 -84.1% 38.83 US$388,250